Skip to main content

MedCloud Minute

Blog archive

Labcorp Expands Consumer Genetic Testing with New Hereditary Risk Panel

Key Takeaways

  • Labcorp launches the Marker Genetic Health Panel, expanding direct-to-consumer hereditary genetic testing and preventive healthcare services.
  • Clinical-grade genetic testing identifies inherited cancer, cardiovascular and hereditary disease risks with genetic counseling support.
  • Marker by Labcorp combines genetic testing, digital results and expert counseling for proactive consumer health management.

Labcorp, a global leader of innovative and comprehensive laboratory services, has expanded its consumer health offerings with the launch of the Marker by Labcorp Genetic Health Panel, a direct-to-consumer test designed to identify inherited genetic risks associated with certain hereditary conditions. The tool was developed to help address this gap by combining clinical genetic testing, specimen collection and genetic counseling into a single consumer healthcare experience.

The new panel analyzes genes linked to inherited cancer syndromes, cardiovascular disease and other genetic disorders, giving consumers access to clinical-grade testing without requiring an initial physician referral. Customers receive digital results and can consult with board-certified genetic counselors to help interpret findings and determine whether follow-up medical evaluation is appropriate. Labcorp said the service is intended to complement, rather than replace, care provided by healthcare professionals.

The new offering reflects growing consumer interest in proactive health management and earlier identification of genetic risk factors that may influence preventive care and treatment decisions. Marker by Labcorp expands the testing options available through Labcorp OnDemand, connecting consumers to both biomarker and hereditary genetic testing through a single trusted source.

Posted by MedCloudInsider Editors on 07/29/2026